Back to LCTX
SAPIENT CAPITAL LLC LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
7
Latest value
$255K
Q3 2026
Peak value
$908K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $705K |
| Q4 2025 | $908K |
| Q1 2026 | $594K |
| Q1 2026 | $594K |
| Q2 2026 | $781K |
| Q2 2026 | $781K |
| Q3 2026 | $255K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $255K | 7.4K | — | — |
| Q2 2026 | $781K | 17.8K | — | — |
| Q2 2026 | $781K | 17.8K | — | — |
| Q1 2026 | $594K | 17.8K | — | — |
| Q1 2026 | $594K | 17.8K | — | — |
| Q4 2025 | $908K | 25.2K | — | — |
| Q3 2025 | $705K | 17.8K | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M